Aboagye EO - Search Results

1

The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography.

Collingridge DR, Carroll VA, Glaser M, Aboagye EO, Osman S, Hutchinson OC, Barthel H, Luthra SK, Brady F, Bicknell R, Price P, Harris AL. Collingridge DR, et al. Among authors: aboagye eo. Cancer Res. 2002 Oct 15;62(20):5912-9. Cancer Res. 2002. PMID: 12384557

2

In vivo monitoring of drugs using radiotracer techniques.

Saleem A, Aboagye EO, Price PM. Saleem A, et al. Among authors: aboagye eo. Adv Drug Deliv Rev. 2000 Mar 15;41(1):21-39. doi: 10.1016/s0169-409x(99)00054-x. Adv Drug Deliv Rev. 2000. PMID: 10699303 Review.

3

Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action.

Saleem A, Yap J, Osman S, Brady F, Suttle B, Lucas SV, Jones T, Price PM, Aboagye EO. Saleem A, et al. Among authors: aboagye eo. Lancet. 2000 Jun 17;355(9221):2125-31. doi: 10.1016/s0140-6736(00)02380-1. Lancet. 2000. PMID: 10902627 Clinical Trial.

4

Pharmacokinetic evaluation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography.

Saleem A, Harte RJ, Matthews JC, Osman S, Brady F, Luthra SK, Brown GD, Bleehen N, Connors T, Jones T, Price PM, Aboagye EO. Saleem A, et al. Among authors: aboagye eo. J Clin Oncol. 2001 Mar 1;19(5):1421-9. doi: 10.1200/JCO.2001.19.5.1421. J Clin Oncol. 2001. PMID: 11230487 Clinical Trial.

5

In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography.

Aboagye EO, Price PM, Jones T. Aboagye EO, et al. Drug Discov Today. 2001 Mar 1;6(6):293-302. doi: 10.1016/s1359-6446(01)01684-1. Drug Discov Today. 2001. PMID: 11257581

6

Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues.

Osman S, Rowlinson-Busza G, Luthra SK, Aboagye EO, Brown GD, Brady F, Myers R, Gamage SA, Denny WA, Baguley BC, Price PM. Osman S, et al. Among authors: aboagye eo. Cancer Res. 2001 Apr 1;61(7):2935-44. Cancer Res. 2001. PMID: 11306471

7

Extraction of 5-fluorouracil by tumor and liver: a noninvasive positron emission tomography study of patients with gastrointestinal cancer.

Aboagye EO, Saleem A, Cunningham VJ, Osman S, Price PM. Aboagye EO, et al. Cancer Res. 2001 Jul 1;61(13):4937-41. Cancer Res. 2001. PMID: 11431319

8

Radiolabelled tracers and anticancer drugs for assessment of therapeutic efficacy using PET.

Brady F, Luthra SK, Brown GD, Osman S, Aboagye E, Saleem A, Price PM. Brady F, et al. Curr Pharm Des. 2001 Dec;7(18):1863-92. doi: 10.2174/1381612013396907. Curr Pharm Des. 2001. PMID: 11772355 Review.

9

Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for pre-phase I positron emission tomography studies in cancer patients.

Aboagye EO, Luthra SK, Brady F, Poole K, Anderson H, Jones T, Boobis A, Burtles SS, Price P. Aboagye EO, et al. Br J Cancer. 2002 Apr 8;86(7):1052-6. doi: 10.1038/sj.bjc.6600212. Br J Cancer. 2002. PMID: 11953847 Free PMC article.

10

Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin.

Liu D, Hutchinson OC, Osman S, Price P, Workman P, Aboagye EO. Liu D, et al. Among authors: aboagye eo. Br J Cancer. 2002 Sep 23;87(7):783-9. doi: 10.1038/sj.bjc.6600558. Br J Cancer. 2002. PMID: 12232764 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters